The First Generation of Biodrug Management: To What Results?

摘要

A few years into the biologic era, payers’ first attempts at managing costs have looked a lot like, well, traditional pharmacy-control methods. The pioneers point to modest savings, but the complexity of biologics, their administration, and lack of competition make a simple cost-saving formula elusive.